Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro
Sandy Goyette,1,2 Yayun Liang,1,2 Benford Mafuvadze,1,2 Matthew T Cook,1,2 Moiz Munir,1,2 Salman M Hyder1,2 1Department of Biomedical Sciences, 2Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, USA Abstract: Clinical trials and studies have shown that combination estrogen...
Main Authors: | Goyette S, Liang Y, Mafuvadze B, Cook MT, Munir M, Hyder SM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-05-01
|
Series: | Breast Cancer: Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/natural-and-synthetic-progestins-enrich-cancer-stem-cell-like-cells-in-peer-reviewed-article-BCTT |
Similar Items
-
Cholesterol biosynthesis inhibitor RO 48-8071 reduces progesterone receptor expression and inhibits progestin-dependent stem cell-like cell growth in hormone-dependent human breast cancer cells
by: Liang Y, et al.
Published: (2017-07-01) -
Chlorpromazine Sensitizes Progestin-Resistant Endometrial Cancer Cells to MPA by Upregulating PRB
by: Yunxia Cui, et al.
Published: (2021-04-01) -
Progestin as an alternative treatment option for multi-treated recurrent triple-negative breast cancer
by: Xiangying Meng, et al.
Published: (2013-05-01) -
The comparison between fixed versus degressive doses of medroxyprogesterone acetate combined with letrozole in patients of progestin-primed ovarian stimulation protocol: a propensity score-matched study
by: Ying Zhang, et al.
Published: (2023-12-01) -
Effect of medroxyprogesterone acetate dose in progestin-primed ovarian stimulation on pregnancy outcomes in poor ovarian response patients with different body mass index levels
by: Qianjie Zhang, et al.
Published: (2024-04-01)